PFIZER
Business purpose.
Commercialisation de produits pharmaceutiques de santé humaine et plus généralement de tous produits pharmaceutiques, para-pharmaceutiques, chimiques, médicaux.
PFIZER is a company registered under SIREN number 433623550, with its registered office in PARIS 14. Its main activity falls under the sector: Wholesale trade, except of motor vehicles and motorcycles. It has 8 establishments. 3 serving directors are recorded in the national business register. Its reported revenue for the financial year ended in 2024 is 2,049,109,460 euros.
Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- 500 to 999 employees
- Created
- 9 Nov 2000
- Share capital
- 47,570.00 EUR
- Registered with the trade register
- 23 Nov 2000
- Financial year end
- 30/11
- Establishments
- 8
Directors
- FRANCK Le Breguero 57 years old, 07/1969 Directeur general
- KPMG Commissaire aux comptes titulaire
- REDA Guiha 63 years old, 11/1963 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- SCI HORUS via REDA Guiha
Court decisions
Decisions published by the French Court of Cassation (Judilibre) that cite this company by its SIREN number. Individuals are pseudonymised.
- Ruling, Cour d'appel de Paris Confirme la décision déférée dans toutes ses dispositions, à l'égard de toutes les parties au recours 2 Oct 2025 · no. 24/19595
Other companies at the same address
38 other company head offices are registered at this address.
Establishments
-
43362355000079 41000 BLOIS
-
43362355000053 35220 CHATEAUBOURG
-
43362355000012 92400 COURBEVOIE
-
43362355000061 92400 COURBEVOIE
-
43362355000038 78280 GUYANCOURT
-
43362355000046 78280 GUYANCOURT
-
43362355000087 37200 TOURS
Financial strength
Financial score
37 / 100 D
Confidence: medium · computed on the financial year ended 30 Nov 2024
- Equity to assets (5.2 %)
- 5.3 out of 30
- EBITDA margin (7.9 %)
- 13.4 out of 25
- Liquidity (118.9 %)
- 4.4 out of 20
- Debt (78.1 %)
- 8.0 out of 15
- Revenue trend (6.9 %)
- 6.0 out of 10
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (26.0 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 30 Nov 2024 | 2,049,109,460 € | +6.9 % | 161,026,588 € | 57,555,853 € |
| 30 Nov 2023 | 1,916,412,692 € | -41.1 % | 11,135,310 € | 110,001,139 € |
| 30 Nov 2022 | 3,256,316,683 € | +13.6 % | 187,820,976 € | 68,274,270 € |
| 30 Nov 2021 | 2,867,006,404 € | +118.8 % | 164,434,008 € | 86,434,715 € |
| 30 Nov 2020 | 1,310,421,167 € | +7.7 % | 70,043,779 € | 13,488,724 € |
| 30 Nov 2019 | 1,216,551,082 € | +29.3 % | 60,622,231 € | 13,202,342 € |
| 30 Nov 2018 | 941,020,343 € | +13.4 % | -6,404,657 € | 15,951,754 € |
| 30 Nov 2017 | 830,135,343 € | +9.3 % | 110,739,060 € | 16,866,661 € |
| 30 Nov 2016 | 759,651,064 € | first year on record | 48,351,134 € | 40,426,096 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in August 2026
Labels and certifications
Gender equality index
-
Gender equality index 2025
92 out of 100
-
Gender equality index 2024
92 out of 100
-
Gender equality index 2023
93 out of 100
-
Gender equality index 2022
98 out of 100
-
Gender equality index 2021
99 out of 100
Group
Links declared to the global Legal Entity Identifier register.
-
consolidated by PFIZER HOLDING FRANCE (FR)
share not disclosed
-
ultimately consolidated by PFIZER INC. (US)
share not disclosed
Accounting consolidation is neither ownership nor control: a company may consolidate a subsidiary it does not wholly own.
Legal notices
-
Filing of accounts 18 Jun 2026
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2025
BODACC C n 20260114, annonce n 12986 · Proof of publication (PDF)
-
Filing of accounts 20 Jun 2025
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2024
BODACC C n 20250117, annonce n 3730 · Proof of publication (PDF)
-
Filing of accounts 9 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2023
BODACC C n 20240131, annonce n 6486 · Proof of publication (PDF)
-
Filing of accounts 19 Jul 2023
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2022
BODACC C n 20230137, annonce n 5376 · Proof of publication (PDF)
-
Amendment 16 May 2023
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur l'origine du fonds d'un établissement principal
BODACC B n 20230094, annonce n 2195 · Proof of publication (PDF)
-
Amendment 18 Sep 2022
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur l'administration
BODACC B n 20220181, annonce n 2271 · Proof of publication (PDF)
-
Filing of accounts 5 Jul 2022
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2021
BODACC C n 20220129, annonce n 8527 · Proof of publication (PDF)
-
Filing of accounts 23 Jun 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2020
BODACC C n 20210121, annonce n 3987 · Proof of publication (PDF)
-
Filing of accounts 19 Jun 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2019
BODACC C n 20200118, annonce n 4005 · Proof of publication (PDF)
-
Filing of accounts 4 Jul 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/11/2018
BODACC C n 20190127, annonce n 12847 · Proof of publication (PDF)
-
Amendment 10 May 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Amendment :
- modification survenue sur l'administration
BODACC B n 20190090, annonce n 3028 · Proof of publication (PDF)
-
Amendment 7 May 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20190088, annonce n 3455 · Proof of publication (PDF)
Public contracts won
444 current contracts
-
Réseau des Acheteurs Hospitaliers 738,204 € · 12 Nov 2026
MN024 _ 2023-R074 _MEDICS NON SUBST _LOT121
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 160,000 € · 19 Oct 2026
SULFASALAZINE ORAL
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 216,400 € · 19 Oct 2026
ALPROSTADIL INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 376,720 € · 19 Oct 2026
VACCIN PNEUMOCOQUE 20/21VALENT
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 465,136 € · 19 Oct 2026
VACCIN PNEUMOCOQUE 13/15VALENT
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 112,320 € · 19 Oct 2026
VACCIN MENINGO ACWY 6 SEMAINES
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 80,800 € · 19 Oct 2026
VACCIN VRS PERSONNE AGEE
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 80,000 € · 19 Oct 2026
VACCIN VRS FEMME ENCEINTE
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 70,051 € · 19 Oct 2026
VORICONAZOLE BUV
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 280,560 € · 19 Oct 2026
LINEZOLIDE BUV
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 40,000 € · 19 Oct 2026
FLUCONAZOLE BUV
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 40,000 € · 19 Oct 2026
AZITHROMYCINE BUV
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 2,279,200 € · 19 Oct 2026
NIRMATRELVIR RITONAVIR ORAL
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 6,661,413 € · 19 Oct 2026
ISAVUCONAZOL ORAL
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 80,000 € · 19 Oct 2026
TIGECYCLINE INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 40,000 € · 19 Oct 2026
SULBACTAM AMPICILLINE INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 6,230,378 € · 19 Oct 2026
ISAVUCONAZOL INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 40,000 € · 19 Oct 2026
CLINDAMYCINE INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 2,752,600 € · 19 Oct 2026
CEFTAZIDIME AVIBACTAM INJ
-
Centre Hospitalier Universitaire de Toulouse (Hôtel Dieu Saint Jacques) 233,804 € · 19 Oct 2026
CEFTAROLINE INJ
Source: essential public procurement data (DECP), Open Licence 2.0. Only the current version of each contract is shown.
Filings and accounts
- Formality 24 Jun 2025
Change history
- employee_range 42 → 41 4 Nov 2026
- employee_range 42 → 41 3 Nov 2026
- officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- registered_address (empty) → 23-25 avenue du Dr Lannelongue 75014 Paris 3 Oct 2026
- capital (empty) → 47570.00 3 Oct 2026
Frequently asked questions about PFIZER
- What is the SIREN number of PFIZER?
- The SIREN number of PFIZER is 433623550. Its intra-community VAT number is FR73433623550.
- Where is the head office of PFIZER?
- Head office address: 23 AV DU DOCTEUR LANNELONGUE, 75014 PARIS 14.
- When was PFIZER founded?
- PFIZER was founded on 9 Nov 2000.
- What does PFIZER do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs PFIZER?
- The officers listed in the register are FRANCK Le Breguero (Directeur general), KPMG (Commissaire aux comptes titulaire), REDA Guiha (President de SAS).
- What is the revenue of PFIZER?
- The latest published revenue is 2,049,109,460 €, for the 2024 financial year.
- How many employees does PFIZER have?
- The declared headcount is 500 to 999 employees. Insee data for 2024.
- Is PFIZER subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.